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Abstract
EBNA3C is an EBV-encoded nuclear protein, essential for proliferation of EBV infected B-
lymphocytes. Using EBNA3C amino acids 365-545 in a yeast two hybrid screen, we found an
interaction with the Growth Arrest and DNA-damage protein, Gadd34. When both proteins are
overexpressed, Gadd34 can interact with EBNA3C in both nuclear and cytoplasmic compartments.
Amino acids 483-610 of Gadd34, including the two PP1a interaction, and the HSV-1 ICPγ34.5
homology domains, are required for the interaction. Furthermore, interaction is lost with a mutant
of EBNA3C (509 DVIEVID 515→AVIAVIA), that abolishes EBNA3C coactivation ability as well as
SUMO interaction[1]. In B-cells, Gadd34, and EBNA3C are present in a complex with PP1a using
microcystin sepharose affinity purification, Using a lymphoblastoid cell line in which EBNA3C
protein levels are conditional on hydroxytamoxifen, surprisingly, we found that (i) EBNA3C
maintains  phosphorylation of eIF2α at serine 51, and (ii) protects against ER stress induced
activation of the unfolded protein response as measured by XBP1 (u) versus XBP1(s) protein
expression and N-terminal ATF6 cleavage. In reporter assays, overexpression of Gadd34 enhances
EBNA3C's ability to co-activate EBNA2 activation of the LMP1 promoter. Collectively the data
suggest that EBNA3C interacts with Gadd34, activating the upstream component of the UPR
(eIF2α phosphorylation) while preventing downstream UPR events (XBP1 activation and ATF6
cleavage).
Background
Epstein-Barr virus is a ubiquitous human herpes-virus that
causes infectious mononucleosis. It remains latent in B-
cells following resolution of infection, however, it has the
potential to be a serious opportunistic pathogen. Expres-
sion of EBV latency III proteins is observed in acute infec-
tion, as well as in EBV positive post-transplant, and X-
linked lymphoproliferative disease (PTLD and XLP) and
HIV associated CNS lymphoma[2]. In this pattern of gene
expression, 6 nuclear proteins (EBNAs 1,2 3A, 3B and 3C),
three integral membrane proteins (LMP1, LMP2a and
LMP2b) and two non-coding poly-adenylated RNAs
(EBERS 1 and 2) are expressed[3,4]. Expression of these
genes converts B-cells to leukemic lymphoblasts in vivo,
and to lymphoblastoid cell lines in vitro. EBNA3C, is
essential for initiation of B-cell growth, as well as ongoing
B-cell transformation. Recombinant EBV containing a
stop codon in the EBNA3C ORF is able to cause B-cell
transformation only when transcomplemented for wild-
type EBNA3C either in cis or trans, and LCLs immortal-
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ized by recombinant EBV containing a conditional
EBNA3C gene, undergo growth arrest when EBNA3C
expression is turned off [5-7]
EBNA3C co-activates transcription with EBNA2 at the
viral LMP-1 promoter, as well as heterologous reporter
systems designed to test p300 function. EBNA3C amino
acids 343-545 were found to be essential for co-activation
in both reporter systems, and yeast two-hybrid studies
established that aa365-545 are sufficient for interaction
with both SUMO-1 and with SUMO-3 [8] We further
established that EBNA3C uses a SUMO interaction motif
(SIM) (aa 507-513) to interact with SUMO-1 and SUMO-
3, and that co-activation with EBNA2, is lost with muta-
tions of the SIM (eg. m2, 509 DVIEVID 515→AVIAVIA) that
prevent SUMO binding, as well as with larger deletions
(eg Δ343-545) that remove the central portion of the pro-
tein including the SIM, but leave other structural domains
(eg the RBP-J-Kappa binding domain) intact [1]. In an
effort to define other transcriptional activators associated
with EBNA3C in SIM dependant manner, we performed a
yeast two hybrid assay using EBNA3C aa365-545 as bait,
and a splenic B-cell yeast two hybrid library as prey.
Suprisingly, EBNA3C was shown to interact robustly with
the Growth Arrest and DNA-damage protein 34
(Gadd34), an ER-associated protein that is up-regulated
in response to viral infection as well as ER-stress. Further-
more, interaction with Gadd34 was lost when we tested a
SIM mutated form of EBNA3C for interaction (m2, 509
DVIEVID 515→AVIAVIA)
In this study we sought understand the effects of the inter-
action between EBNA3C and Gadd34 on transcriptional
co-activation with EBNA2 at, the -512/+72 LMP-1 pro-
moter. Since Gadd34 is involved in resuming protein syn-
thesis following resolution of ER stress, by functioning as
a phosphotase subunit towards eIF2α, we also sought to
investigate EBNA3C effects on the unfolded protein
response in EBV infected B-lymphocytes.
In this study, we map a region important for EBNA3C
interaction with Gadd34, and show that Gadd34 can
cooperate with EBNA3C in co-activation of the LMP1 pro-
moter with EBNA2, in a manner that depends on EBNA3C
interaction with Gadd34, but appears independent from
Gadd34 binding to PP1a. Using a cell line (LCL C19-9)
conditional on Tamoxifen for EBNA3C expression, sur-
prisingly, we find that EBNA3C expression results in an
increase in eIF2α serine 51 phosphorylation, an early
event in both the PKR and unfolded protein responses.
Paradoxically, EBNA3C protected against downstream
events in the UPR, namely the switch from expression of
unspliced to spliced XBP1 isoforms, as well as ATF6 cleav-
age. EBNA3C's interaction with Gadd34 may therefore
sustain LMP1 promoter activation in latency III infection,
while preventing stress-induced activation of the UPR.
Materials and methods
Plasmids
Plasmids psg5-EBNA2, psg-5 EBNA3C 11-992, psg-5
EBNA3C 11-992 509DVIEVID515→509AVIAVIA515(M2) and
reporter plasmids -512/+72 LMP-1-Luc, and pgkB-Gal,
have been described previously. Plasmids pAS EBNA3C
aa365-545 was constructed by subcloning the BamHI/SalI
fragment from pGEX-3X-EBNA3C aa365-545 into the
BamHI and SalI sites of pAS-1 (Gift of S. Elledge). pAS
EBNA3C aa365-545-M2 was constructed by subcloning
the SpeI/AatII fragment from psg-5 EBNA3C-M2 into
pAS-1 EBNA3C aa365-545. psg5-Flag-Gadd34 1-674,
180-674, 180-610 and 180-483 were kindly provided by
M Brush and S Shenolikar, Duke University.
Antibodies
Anti-human Gadd34(ab9869), anti-XBP1 (ab37152),
anti-Laminin B (ab16048), and anti-eIF2α (ab5369) anti-
bodies were purchased from Abcam Inc. Anti-phospho-
eIF2α (Ser51) antibody was obtained from Cell Signaling
Technology. Anti-EBNA3C was purchased from Exalpha
Biologicals Inc. Anitbody recognizing only the spliced
XBP1 isoform was obtained from Biolegend. Anti-ATF6
antibody, recognizing only the 90 KDa isoform, was
purched from Imgenex (San-Diego, CA). Anti-β-actin
(A1978) antibody was obtained from Sigma-Aldrich.
Yeast two hybrid analysis
50 μg of pAS-1 EBNA3C aa365-545 and a pACT library
were co-transformed into 1.5 mL of log phase yeast strain
AH109. Yeast were spread on 40 150 mM synthetic drop-
out (SD) plates (Leu-, Trp-, His-, Ade-,β-gal) After 2 weeks
of growth, 88 blue colonies were selected and replated on
SD plates (Leu-, Trp-, His- +25 mM 3-AT). 43/88 colonies
that grew under these conditions, were selected and trans-
forming plasmids segregated by two cycles of liquid cul-
ture amplification and restreaking SD (Leu-, Trp-, X-β-gal
plates), yielding a mixture of blue and white colonies.
Blue colonies were picked and yeast minipreps per-
formed, followed by transformation of DH5α MAX Effi-
ciency cells (Life Technologies, Rockville, MD) and
miniprep. Duplicate cDNAs were identified by PCR across
the pACT MCS, followed by Alu digest of PCR products.
Unique cDNAs were then retested by retransformation
into AH109 cells and growth on SD media (Leu-, Trp-, His-
, Ade-.) Confirmed interactors were selected for parallel
retransformation of AH109 with EBNA3C 1-992,
EBNA3C aa365-545 or EBNA3C aa365-545 M2, followed
by plating on SD media (Leu-, Trp-, His-, Ade-).
Microcystin pulldowns and Co-immunoprecipitation
4 million BJAB or BJAB-E3C cells were collected and lysed
in 1 mL buffer containing 0.5% NP-140, 150 mM NaClVirology Journal 2009, 6:231 http://www.virologyj.com/content/6/1/231
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with or without added 0.5% BSA. Lysates were incubated
for 1 hour or overnight with either protein G sepharose
(Amersham Pharmacia, Piscataway, NJ) or microcystin
sepharose (Upstate, Lake Placid, NY). Proteins were
resolved by electrophoresis and EBNA3C and Gadd34
were detected using mouse monoclonal A10 antibody,
and anti-Gadd34 rabbit polyclonal antibody (C-20, Santa
Cruz) For IB4 co-immunoprecipitation experiments, 15
million IB4 cells were lysed in RIPA buffer (1% NP-40, 1%
sodium deoxycholate, 0.1% SDS, 0.15 molar NaCl, 0.01
molar sodium phosphate, pH 7.2) for 30 minutes. Insol-
uble matrix was pelleted by centrifugation at 12 000 RPM
for 10 minutes, and clarified lysates pre-cleared with pro-
tein-G-sepharose. Protein-G-Sepharose or Protein-G
sepharose with A10 antibody were added to lysates which
were incubated with rotation at 4 degrees overnight. Fol-
lowing IP, proteins were resolved by electrophoresis and
Gadd34 detected using C-20 antibody.
Reporter Assays
BJAB cells (107) were transfected in 0.4 mL of RPMI 1640
supplemented with 10% Neugem serum with a Bio-Rad
gene pulser at 200V and 960 μF. Each transfection con-
tained 5 ug of -512/+72 LMP1-Luc plasmid and 5 ug pgk-
B-Galactosidase plasmid as a normalization control, and
the indicated microgram amounts of psg5-EBNA2, psg5-
EBNA3C or psg5-Gadd34 plasmids. Total plasmid DNA
was made equal across transfections by the addition of
psg5 vector DNA. After transfection, cells were placed in
10 mL of complete medium and incubated at 37 for 24
hours. Cells were collected, washed in phosphate buffered
saline, lysed in reporter buffer (Luciferase Assay System,
Promega, Madison, WI) by one freeze thaw cycle, and
assayed for luciferase and beta-galactosidase activities
(Galacto-Light; Tropix) with an Opticomp I luminometer
(MGM instruments.)
Stress assays
LCL C19-9 cells were maintained in RPMI 1640 suple-
mented with 15% FBS in the presence of 400 nM - hydrox-
ytamoxifen (4-HT) (Sigma-Aldrich), and then transferred
to medium containing either 4 HT or DMSO for 9 days.
Six hours prior to harvest, cells were treated with Thapsi-
gargin (0.5 μM) to induce ER stress and activate the UPR.
Following treatment cells lysed were prepared using RIPA
buffer. Protein concentration was measured using Bio-
Rad protein asssay. Equal amounts of protein (20 μg)
were separated by SDS-PAGE and protein transferred to a
PVDF membrane. Blots were blocked by incubation for 1
h at room temperature in 3% bovine serum albumin
(BSA) in TBS buffer (10 mM Tris HCl pH 7.6; 150 mM)
containing 0.1% Tween-20 (TBS-T). The membranes were
incubated overnight with the indicated primary antibod-
ies diluted in 1% BSA in TBS-T. Membranes then were
washed 3 times for 10 min with TBS-T followed by incu-
bation with the appropriate secondary antibodies diluted
in 1% BSA in TBS-T for 1 h at room temperature. Finally,
membranes were washed 5 times with TBS-T buffer for 15
min and immunoreactivity was detected using ECL system
obtained from Millipore.
Results and Discussion
The EBNA3C SUMO interaction motif is required for 
interaction with Gadd34
Yeast two-hybrid screening using EBNA3C aa365-545 as
bait, revealed one of the interactors to be the protein
encoded by pACT-Gadd34 aa395-674. Interaction was
confirmed with a β-galactosidase filter lift assay, after an
half hour incubation. Previous studies showed that
EBNA3C aa365-545 containing the m1 (507 DDDVIEVID
515→DDAVIAVIA) and m2 (507DDDVIEVID
515→AAAVIEVID) interact very weakly with SUMO-1
and fail to interact with SUMO-3[1]. To test whether inter-
action between EBNA3C and Gadd34 also depends on the
SUMO interaction motif, the m2 mutation was con-
structed in the context of EBNA3C aa365-545, and tested
against Gadd34 aa395-674 (Table 1). While wild type
EBNA3C aa365-545 interacted with Gadd34, interaction
was lost when the m2 mutant was tested. As expected,
wild type EBNA3C aa365-545 but not the m2 mutant,
interacted with SUMO-3 [1]. Therefore EBNA3C aa365-
545 interaction with Gadd34 depends on the presence of
an intact SUMO interaction motif, a domain of EBNA3C
also required for transcriptional co-activation with
EBNA2.
In order to test whether full length EBNA3C interacts with
Gadd34, the Gal4 DNA binding domain was fused N-ter-
minal to the entire EBNA3C ORF (aa1-992), cloned into
Y2H vector pAS-1, and tested against pACT-Gadd34
aa395-674. As a positive control a cDNA encoding full
length RBP-J-Kappa, cloned into pACT, was tested for
interaction with EBNA3C under the same conditions. Full
length EBNA3C interacted with Gadd34aa395-674, as
Table 1: Focused yeast two-hybrid assays
1-992 aa365-545 aa365-545 m2
SUMO-3 ++ +++ -
RBP-J-κ +++ - -
Gadd34 ++ +++ -
Focused yeast two-hybrid assays testing the interaction of full-length 
EBNA3C, EBNA3C aa365-545 Yeast strain AH109 were transformed 
in parallel with pAS1-EBNA3C (1-992), pAS-WT EBNA3C (aa365-
545) or with the SIM (M2) mutant (aa365-545, 
509DVIEVID515→509AVIAVIA515) and tested for interaction with 
pACT-Gadd34aa395-674. Colonies were sampled using a filter lift 
assay and interaction confirmed using a LacZ assay. Results of a 1 
hour LacZ assay, scored semi-quantitatively, are shown.Virology Journal 2009, 6:231 http://www.virologyj.com/content/6/1/231
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well as with RBP-J-Kappa, and LacZ conversion occurred
within 30 minutes for both interactions.
These data indicate that EBNA3C interacts with
Gadd34aa395-674, and that the interaction is comparable
in affinity to the interaction between EBNA3C and RBP-J-
κ. Furthermore, EBNA3C aa365-545 interaction with
Gadd34aa395-674 depends on the SUMO interaction
motif. These data also suggest that Gadd34 may, in part,
be a mediator of EBNA3C co-activation function.
EBNA3C interaction with Gadd34 requires Gadd34 amino 
acids 483-610
To test whether EBNA3C can interact with Gadd34 in
human cells, and to better understand the domains of
Gadd34 responsible for interaction with EBNA3C, 293T
cells were transfected with expression vectors encoding
either EBNA3C alone (figure 1, lane 1), flag-tagged full
length Gadd34 alone (lane 2), both full length EBNA3C
and Flag-tagged-Gadd34 (lane 3) or combinations of
EBNA3C and the indicated Gadd34 constructs as indi-
cated (lanes 4-6). Transfected Gadd34 was immunopre-
cipitated using sepharose beads coupled with anti-flag
antibody (M2 beads), and interaction with EBNA3C
tested by western blotting for both Gadd34 and EBNA3C.
Both full length Gadd34(1-674), as well as an N-terminal
truncation mutant (180-674) interacted with EBNA3C
(lanes 3 and 4). Interaction was enhanced with further
deletion of Gadd34 amino acids 611-674 (lane 5), how-
ever interaction was lost when Gadd34 aa180-483 was
tested. This data indicates that Gadd34 interaction with
EBNA3C requires Gadd34 amino acids 483-610. This
domain includes the sequences 555-558 KVRF, and 612-
616 RARA, which when mutated (KVRF→KARA) or
deleted (ΔRARA), reduce activation and association with
PP1a respectively. In lane 7, 3% of starting lysates prior to
M2 flag pulldown is shown.
EBNA3C interacts with Gadd34 and PP1a in human B cells
To test whether EBNA3C interacts with Gadd34 in human
B-cells, the lymphoblastoid cell line IB4, which contains
integrated copies of the EBV B95-8 genome, was used.
EBNA3C was immune precipitated from RIPA lysates,
using protein G sepharose followed and A10 anti-
EBNA3C antibody. Immunoblotting for Gadd34 revealed
that EBNA3C associates with Gadd34 in IB4 LCLs (Figure
2a.)
In order to test whether EBNA3C resides in PP1a com-
plexes in cells, microcystin sepharose was applied to RIPA
buffer whole-cell lysates from BJAB cells which do not
express EBNA3C or BJABs stably expressing EBNA3C (Fig-
ure 2b) Addition of protein G sepharose failed to immune
precipitate EBNA3C from wild type BJABs or BJABs stably
expressing EBNA3C (Figure 2b, lanes 5 and 6). Likewise
microcystin sepharose failed to immune precipitate
EBNA3C in wild-type BJABs (lane 3). However when
microcystin sepharose was applied to BJABs stably
expressing EBNA3C, a small amount, representing
approximately 3-5% of input EBNA3C, co-precipitated
(lane 4). In transient transfection experiments in 293T
cells, EBNA3C was able to interact with Gadd34 in both
cytoplasmic and nuclear compartments (data not shown).
Microcystins are cyclic heptapeptides synthesized by blue-
green algae that covalently couple to the catalytic subunits
of protein phosphotases PP1 and PP2a [9]. Although not
completely specific to PP1a, taken together, the data indi-
cate that both EBNA3C and Gadd34 reside in protein
phosphotase complexes in B cells.
Gadd34 overexpression enhances EBNA3C transcriptional 
co-activation with EBNA2
Since Gadd34 interaction with EBNA3C depends on a
motif that is also required for transcriptional co-activation
by EBNA3C reporter assays in the Burkitt's lymphoma cell
line, BJAB were used to assess Gadd34 affects on EBNA3C
co-activation. The reporter chosen was -512/+72 of the
LMP-1 promoter fused to luciferase, which contains two
RBP-J-Kappa binding sites, and is reliably activated by
EBNA2 and further activated by EBNA3C [8]. This region
Gadd34 aa 483-610 are required for EBNA3C association Figure 1
Gadd34 aa 483-610 are required for EBNA3C associ-
ation. a) 293-T cells were seeded in 6-well plates resulting in 
70% confluence by day 2, and transfected with 0.5 μg of 
either psg5-EBNA3C alone (lane 1), psg5-Flag-Gadd34 (full-
length, aa1-674, lane 2), or both EBNA3C and Flag-Gadd34 
(1-674) (lane 3). In lanes 4-7 a combination of EBNA3C and 
the indicated Gadd34 mutants were transfected. Total DNA 
was 1.0 μg for each transfection. 18 hours post-transfection, 
cells were lysed in isotonic buffer containing 0.5% NP-40. 
Gadd34 or Gadd34 mutant proteins were immune precipi-
tated with anti-flag affinity beads (M2-agarose), and precipi-
tating proteins western blotted with α-EBNA3C antibody 
(A10) (top panel) or Flag antibody (bottom panel). In lane 7, 
3% of starting lysates prior to immune precipitation (input) 
from the well transfected with psg5-EBNA3C alone (top 
panel), or psg5-Flag-Gadd34 alone (bottom panel) is shown.
IP:Flag (Gadd34)
WB:a-E3C
WB:Flag (Gadd34)
1-674 180-674 180-483 180-610
E3C E3C E3C E3C E3C
1-674
3% input
E3C
1-674Virology Journal 2009, 6:231 http://www.virologyj.com/content/6/1/231
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of the LMP1 promoter also includes an ER stress response
element (ERSE) located at position -146 relative to the
transcriptional start site, recently shown to be important
for LMP1 promoter activation by ER stress inducing chem-
icals (eg Brefeldin A, Tunicamycin) or by overexpression
of the ER-stress transactivator, XBP1 [10].
LMP-1 promoter activity levels observed with expression
of EBNA2 alone was normalized to 1, (Figure 3a, lane 1).
Co-transfection of 10 μg EBNA3C expression plasmid
increased reporter activity levels to over 32 fold that
observed with EBNA2 alone (lane 2) while co-expression
of EBNA3C and full length Gadd34 resulted in a further
~2.0 fold (from 32.2 to 62.0) increase in promoter activity
levels (lane 5). Full length Gadd34 (aa 1-674, lane 5) and
Gadd34 180-610 (lane 3) were equally effective in coop-
erating with EBNA3C, while full length Gadd34 had no
effect on basal LMP1 reporter activity or EBNA2 activity in
the absence of EBNA3C (data not shown). Gadd34 effects
on LMP1 promoter activity depended on both EBNA2 and
EBNA3C expression. In order to test whether the ability of
Gadd34 to synergize with EBNA3C in the co-activation of
EBNA2 at the LMP1 promoter, depended on Gadd34
binding to PP1a, point mutants known to affect PP1a
activity (555KVRF558→KARA) or association (612-
616ΔRARA) were tested in the same reporter assay (figure
3a). A 2-2.5 fold potentiation of EBNA3C promoter activ-
ity was again observed with both the KVRF (73.9 vs 72.5
for WT Gadd34) as well as ΔRARA (74.7 vs 72.5 for WT
Gadd34) mutants (lane 2 versus lanes 5, 6 and 7). These
data suggest that enhancement of EBNA3C activity by
Gadd34 does not depend on association with PP1a.
When a smaller quantities (100 ng) of EBNA3C expres-
sion plasmid were used in the same experiment, EBNA3C
expression increased LMP-1 promoter activity levels sub
maximally to 5.5 fold relative to EBNA2 alone (Figure 3b,
lane 2), and this was enhanced approximately 5-fold by
the co-transfection of 10 μg of plasmid expressing Gadd34
(Figure 3b, lane 8). Gadd34 was able to potentiate
EBNA3C transcriptional co-activation in a dose depend-
ant manner (lanes 6-8). By contrast, a dominant negative
effect on EBNA3C activity was observed with overexpres-
sion of a Gadd34 truncation mutant that cannot bind
EBNA3C (Gadd34 aa180-483, figure 3b, lanes 3-5).
EBNA3C expression is associated with eIF2a serine 51 
phosphorylation
EBNA3C interaction with Gadd34 might effect eIF2α
phosphorylation, because Gadd34 recruits PP1a to the ER
where the Gadd34/PP1a holoenzyme dephosphorylates
eIF2a at serine 51. In order to determine EBNA3C effects
on eIF2α activation, we used a cell line (LCL-19-9) in
which EBNA3C expression is controlled by hydroxyta-
moxifen. Aliquots of these cells were maintained in media
containing hydroxytamoxifen and then transferred to
media with (+HT) or without (-HT) hydroxytamoxifen,
for 8-10 days. Lysates were prepared and western blotted
for the indicated proteins (Figure 4a) As expected with this
cell line, withdrawal of hydroxytamoxifen resulted in
slowed cell growth over a period of 8-10 days, accompa-
nied by loss of EBNA3C-HT protein expression. While
total eIF2α levels were comparable in cells grown in the
presence of absence of tamoxifen, a significant difference
in serine 51 phosphorylation was observed, with little
effect on total eIF2α levels (Figure 4a).
EBNA3C interacts with Gadd34 by co-IP and co-purifies with  Gadd34 by microcystin pulldown Figure 2
EBNA3C interacts with Gadd34 by co-IP and co-puri-
fies with Gadd34 by microcystin pulldown. a) IB4 cells 
(5 million for each treatment) were collected, lysed in isot-
onic 0.5% NP-40 buffer, and immune precipitations (IP) per-
formed with either protein G alone (PG) or protein G with 
the addition of anti-EBNA3C (A10) sera (PG/anti-EBNA3C) 
Proteins were western blotted for Gadd34 (SC-H193), fol-
lowing IP. b) Burkitt's lymphoma BJAB cells or BJAB-
EBNA3C cells (5 million for each treatment) were collected, 
lysed in isotonic 0.5% NP-40 buffer, containing additional 
0.5% BSA, and incubated with the indicated sepharose beads 
conjugated to either protein G or microcystin LR. Lysates 
and beads were rotated for 1 hr at 4 degrees, extensively 
washed with PBS, and affinity purified proteins western blot-
ted for the presence of EBNA3C (E3C) and Gadd34.
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EBNA3C protects against thapsigargin induced 
endoplasmic reticulum stress
ER stress results in the endonucleolytic cleavage 26 nt of
sequence from the XBP1 mRNA by the ER resident pro-
tease IRE1. The protein that is translated from the
unspliced XBP1(u) mRNA, gives rise to a 33 Kda protein,
XBP1 (u) with a functional DNA binding domain, but no
activation domain. Following splicing by IRE1, a
frameshift is introduced into the mRNA, resulting in the
translation of a 54 Kda protein, XBP1(s) containing both
DNA binding and activation domains. ATF6 is normally
bound to the ER resident protein, Bip/GRP68. Upon accu-
mulation of unfolded proteins in the ER, Bip dissociates
from ATF6, and ATF6 translocates to the golgi where it is
cleaved by site 1 and site 2 proteases, resulting in the dis-
appearance of the full length 90 KDa protein, and the
appearance of 50 KDa and other lower molecular weight
cleavage products. XBP1(s) and cleaved ATF6 activate dis-
tinct and overlapping sets of proteins (such as chaperones
and protein disulfide isomerases) important for resolu-
A: Gadd34 co-activation with EBNA3C requires aa483-610, and is independent of PP1 recruitment Figure 3
A: Gadd34 co-activation with EBNA3C requires aa483-610, and is independent of PP1 recruitment. A) BJAB 
cells (1 × 107) were transfected with 5 μg of (-512/+72) LMP1p-Luc reporter construct, and 2 μg of psg5-EBNA2 (all lanes). 
psg5-EBNA3C (5 μg) was transfected(lanes 2-7). Gadd34 expression constructs were transfected as indicated (lanes 3-7) Luci-
ferase values were normalized over beta-galactosidase levels obtained with co-transfection of 5 μg pgk-β-Gal plasmid. 
Reporter activation observed with EBNA2 alone is normalized to 1 (lane 1). Values are averages of duplicate observations in 
each experiment (repeated 3 times) plus standard error. A representative experiment is shown. B: Gadd34 180-483 is 
dominant negative in a low-dose EBNA3C co-activation assay. Reporter assay in BJAB cells with the indicated quanti-
ties of expression plasmids, as in figure 3a except that 100 ng (versus 5 μg) of psg5-EBNA3C expression plasmid was used. 
Each Gadd34 plasmids was titrated to determine stochiometry effects on EBNA3C, transfected at 0.1, 1.0 or 10.0 μg of DNA. 
C: Gadd34 does not co-activate transcription with EBNA2 in the absence of EBNA3C Reporter assay in BJAB cells 
with the indicated quantities of expression plasmids as in figure 3b. A representative experiment is shown. Protein expression 
levels of flag-tagged Gadd34, EBNA2 and EBNA3C are shown below.
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tion of ER stress during the UPR [11]. Thapsigargin
induces ER stress by inactivating the ER Ca2+  ATPase
resulting in depletion of Ca2+ from the luminal ER, and
dysfunction of Ca dependant ER proteins such as cal-
nexin.
In order to determine whether EBNA3C affects the UPR in
LCLs, LCL C19-9 was maintained in the presence or
absence of hydroxytamoxifen as in 4a. Four hours prior to
harvest, cells were incubated in either DMSO alone (Fig-
ure 4b, "C") or in 0.5 μM Thapsigargin ("Tg"). Lysates
from each treatment were blotted for the indicated pro-
teins. All of the XBP1 protein was present in the unspliced
form in control cells growing expressing EBNA3C-HT
(Figure 4b, lane 1). Incubation with Thapsigargin resulted
in a decrease in unspliced XBP1 protein (lane 2), and an
increase in spliced XBP1. By contrast, in LCLs lacking
EBNA3C-HT expression, XBP1(s) was detectable at base-
line (lane 3), and XBP1(s) levels increased dramatically
following the addition of thapsigargin (lane 4). Corre-
spondingly, no XBP1(u) protein was detectable in LCLs
exposed to Thapsigargin, in the absence of EBNA3C-HT.
Similarly, while Thapsigargin resulted in a modest
decrease in full-length, 90 KDa ATF6 in cells growing in
the presence of EBNA3C-HT (band indicated by an aster-
isk, compare lane 1 to lane 2), in the absence of EBNA3C-
HT, the 90 KDa form of ATF6 was undetectable (lane 4).
Collectively these data strongly implicate EBNA3C in pre-
venting LCLs from undergoing UPR signaling, following
ER stress.
Conclusion
In this study, a yeast two-hybrid assay was conducted to
reveal further EBNA3C interacting proteins. In particular
our primary intention was to find novel proteins that
might give clues as to the mechanism of EBNA3C tran-
scriptional co-activation with EBNA2. Surprisingly, the
two-hybrid assay failed to reveal convincing interactions
with  bona-fide  nuclear transcription factors. Rather an
interaction was discovered between EBNA3C and the
translation control protein, Gadd34, and robustly con-
firmed in human cells by immune precipitation. Since
mutations that affect SUMO-1 and SUMO-3 binding also
affect the ability of EBNA3C to bind to Gadd34, as well as
EBNA3C's ability to co-activate transcription with EBNA2,
a genetic and biophysical link has been established
between EBNA3C SUMO and Gadd34 binding and
EBNA3C transcriptional activity. Further experiments
clearly indicated that full length Gadd34, including aa
483-610 which were required for EBNA3C interaction,
have a synergistic effect with EBNA3C in co-activating
transcription with EBNA2 at the LMP1 promoter, while
having no effect on EBNA2 driven reporter activity in the
absence of EBNA3C. Indeed, a mutant of Gadd34, FL-
Gadd34 aa180-483, acted as a dominant negative in
reporter assays. It is known that the chromatin remode-
ling SWI-SNF protein, Ini-1 also associates with the C-ter-
minus of Gadd34 explaining the positive effect on
transcription. At higher concentrations (1 and 10 micro-
grams), Gadd34 180-483 functioned as a dominant nega-
tive, reversing EBNA3C coactivation. Since this mutant
does not associate with EBNA3C, and is therefore likely
not targeted to sites of EBNA3C activity on chromatin, the
effect is likely due to swamping of the cell with Gadd34
protein, and sequestration of a positively acting factor
such as the histone-acetyl transferase CBP, which is
known to be required for full EBNA2 activity at the LMP1
promoter.
EBNA3C, a nuclear protein, would not be expected to
interact with Gadd34, a cytosolic and ER-associated pro-
tein. However, EBNA3C might have the opportunity to
associate transiently with Gadd34 at the ER following
translation, during dismantling of the nuclear lamina dur-
ing mitosis, or during lysosomal or proteasome or medi-
ated degradation. Indeed EBNA3C and EBNA3A have
been shown to associate with cytosolic proteasome subu-
nits [12] Furthermore, while genetic studies have proven
a role for EBNA3C in maintaining growth of EBV trans-
A: EBNA3C effects on phosphorylation the translational con- trol protein eIF2α Figure 4
A: EBNA3C effects on phosphorylation the transla-
tional control protein eIF2α. LCL 19-9 was maintained in 
the presence (+HT) or absence (-HT) of hydroxytamoxifen 
for 10 days. Shown are western blots from whole-cell lysates 
against EBNA3C (top row), serine 51 phosphorylated eIF2α 
(second row), total eIF2α (third row) and β-actin loading 
control (fourth row). By day 10, in the absence of HT, 
LCL19-9 cells had stopped dividing [7]. B: EBNA3C pro-
tects LCLs from activating the unfolded protein 
response. As in Figure 4a except that cells were also treated 
with either DMSO "C" or 0.5 μM Thapsigargin "Tg", for the 4 
hrs preceding harvest. XBP1(s) and XBP1(u) were individu-
ally detected using isoform specific antibodies. An ATF6 anti-
body that detects only full length, uncleaved ATF6 (90 KDa) 
was used (Imgenex, San Diego, CA).
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formed B-lymphocytes, and EBNA3C biochemically frac-
tionates to the nuclear compartment, it is unknown at
present whether nuclear localization of EBNA3C per se, is
required for EBV immortalization.
How might Gadd34 be important for EBNA3C transcrip-
tional activity? One hypothesis, supported in the current
study, is that EBNA3C negatively regulates Gadd34,
decreasing the Gadd34-dependant PP1a recruitment to
eIF2α, and consequently, increasing eIF2α phosphoryla-
tion. Since nuclear translocation of transcription factors
involved in the PKR and UPR responses (such as ATF4,
ATF6 and XBP1) usually occur downstream of eIF2α ser-
ine phosphorylation, a negative effect on Gadd34 func-
tion might be expected result in higher levels or greater
activity of these transcription factors in the nucleus.
Indeed there are numerous ATF4/XBP1 binding sites in
the native LMP1 promoter as well as the -512/+72 con-
struct used in this study, and expression of LMP1 has
recently been shown to exert a feed forward effect by
increasing eIF2α serine 51 phosphorylation, and down-
stream activation of ATF 4 [13]. At least two ER stress
inducible elements have been described. These are con-
trolled by ER stress induced transcription factors as well as
XBP1. The first at position -41 relative to the transcrip-
tional start site of the LMP1 gene, appears active in LCLs,
is responsible for both EBNA2 dependant and EBNA2
independent activation of the LMP1 promoter in reporter
assays, and is regulated by binding of ATF transcription
factors [13-15]. The other ERSE (position -146) is active in
NPC but not B-lymphocyte cell lines and is strictly
required for LMP1 promoter activation by XBP1 overex-
pression or ER stress inducing chemicals such as Brefeldin
A [10] Our initial hypothesis, therefore, was that EBNA3C
potentiated UPR signaling, via an interaction with
Gadd34, increasing ATF 4/6 and/or XBP activity, to co-
activate LMP1 reporter activity with EBNA2.
Consistent with a negative effect on Gadd34 activity,
EBNA3C expression was indeed associated with increased
eIF2α serine 51 phosphorylation. Surprisingly, however,
we found that EBNA3C expression was associated with
lower  levels of active XBP1(s), higher levels of inactive
XBP(u), and increased levels of uncleaved (inactive) ATF6
protein in lymphoblastoid cells. Assuming that ATF and
XBP transcription factors exert a positive effect on the
LMP1 promoter in LCLs, Gadd34 is therefore unlikely to
potentiate EBNA3C transcriptional effects by positively
regulating ATF or XBP1 activity.
In our hands, EBNA3C's protective effects in LCLs appear
similar to effects of the chemical Salubrinal on LCLs (data
not shown), which has the effect of maintaining low lev-
els of serine 51 phosphorylated eIF2α while preventing
downstream events of the UPR such as the switch from
XBP(u) to XBP1(s) protein expression, and activation by
proteolytic cleavage of ATF6 in the Golgi. Salubrinal has
been shown to protect neurons against ER-stress induced
apoptosis, and EBNA3C may perform a similar role in
LCLs[16]. Interestingly, Salubrinal also effects the effi-
ciency of HSV-1 lytic replication, possibly through coun-
teracting the effect of ICPγ34,5 on maintaining eIF2α
dephosphorylation [17]. During the course of Coronavi-
rus infection, eIF2a is also phosphorylated, resulting in a
decrease in translation of host mRNAs, presumably favor-
ing viral mRNA translation [18]. Although it is clear that
EBNA3C expression is associated with eIF2α serine 51
phosphorylation, it is not clear why EBNA3C expression
should result in eIF2α phosphorylation, a condition that
would normally slow protein translation. Under condi-
tions of eIF2a phosphorylation, the major alternative
translational initiation factor eIF4 remains active, and
translation is skewed towards 7-methylguanosine capped
mRNAs, such as the mRNA for c-myc. Translation of viral
rather than cellular RNAs may also be favored in this state.
Further studies are needed to determine if EBNA3C is
associated with a switch in translation from cellular to
viral and oncogenic proteins.
Gadd34, PP1a and EBNA3C reside in a complex in
Burkitt's lymphoma cells converted to permanent
EBNA3C expression, using microcystin sepharose affinity
purification of PP1 complexes. Overexpression of Gadd34
and EBNA3C in transient transfection experiments in
293T cells indicates that EBNA3C can interact with
Gadd34 in both nuclear and cytoplasmic compartments.
For instance, EBNA3C may delocalize Gadd34 to the
nucleus, thereby decreasing the rate of PP1 recruitment,
and consequently, increasing eIF2a phosphorylation.
Prolonged ER stress can result in apoptosis via ASK1 bind-
ing to IRE1, JNK activation, and phosphorylation of Bcl2
or CHOP mediated downregulation of Bcl2 levels[19] It
therefore it seems plausible that EBNA3C is anti-apoptotic
under conditions of prolonged ER stress such as might
occur during initial EBV infection of resting B lym-
phocytes. XBP1, in concert with protein kinase D, can acti-
vate lytic EBV promoters such as the BZLF1 (Zta)
promoter [20] Consistent with tight control of type III
latency, we detect minimal XBP1(s) protein under normal
LCL growth conditions, slightly increased XBP1 (s) pro-
tein upon EBNA3C withdrawal, and robust XBP1(s)
expression under conditions of EBNA3C withdrawal in
the face of chemical induced ER stress. We have also dem-
onstrated that LCLs lytic promoters such as BZLF1, BMRF1
and BRLF1 are activated by Thapsigargin (manuscript in
preparation). It seems likely, therefore, that one function
of EBNA3C would be to maintain type III latency restric-
tion, via shutoff of the UPR. Physiologically, EBV infected
B-lymphocytes may be forced into lytic reactivation in theVirology Journal 2009, 6:231 http://www.virologyj.com/content/6/1/231
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oropharyngeal mucosa, possibly undergoing ER stress sec-
ondary to BCR activation.
EBNA3C effects on transcriptional co-activation with
EBNA2 may be separable from effects on the UPR, because
the Gadd34 specific enhancement of EBNA3C transcrip-
tional effects is maintained with overexpression of a
Gadd34 mutant deficient in PP1a binding. However these
results should be interpreted with caution. While the
ΔRARA mutation eliminates PP1a binding, protein phos-
photases are notoriously unstable in cells. Therefore
apparent loss of PP1a interaction observed with this
mutant, may in fact merely represent decreased associa-
tion, and it is more likely that these mutations reduce
PP1a phosphotase function and interaction rather than
abolish it completely[21].
While viral infection activates PKR via dsRNA or inter-
feron, PERK can be activated by ER stress. Both pathways
of kinase activation occur during viral infection. Both PKR
and PERK can phosphorylate eIF2α at serine 51, arresting
cellular protein synthesis, as well as the synthesis of latent
or lytic viral proteins. Gadd34 recruits PP1a to the endo-
plasmic reticulum where it dephosphorylates eIF2α, and
is therefore essential in maintaining protein synthesis dur-
ing viral infection[22,21] Herpesviruses have evolved
mechanisms to counteract both PKR activation via Us11
expression, and eIF2α phosphorylation through ICPγ34.5
expression. Specifically, the HSV-1 encoded ICPγ34.5 pro-
tein accelerates and maintains the dephosphorylated state
of eIF2α to ensure ongoing translation of viral mRNAs
[23]. In this study, EBNA3C expression had the opposite
effect, increasing rather than decreasing eIF2a phosphor-
ylation, while paradoxically preventing the activation of
downstream UPR. EBNA3C may therefore use the UPR
pathway to alter the levels, activity, or network associa-
tion, of numerous transcription factors in infected B cells,
thereby modulating transcription of essential viral (eg
LMP1) and cellular genes, while preventing UPR signal-
ing, lytic reactivation, and downstream ER stress induced
apoptosis.
These data presented in this study provide motivation for
further studies of the effects of EBNA3C and other latency
III proteins on the unfolded protein and PKR responses in
EBV infection.
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